Named on 7 rounds in the feed, most often in AI.
Rounds from 2025-02-25 to 2026-11-12
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Orakl Oncology A French TechBio company using AI and real patient biology to predict how cancer drugs will perform in clinical trials | Series A Verified against 4 of 14 sources | $33.4M | 2026-11-12 | [ PART ] |
Enact Intelligence A physical AI company building robots that can see their surroundings and sense physical forces acting upon them | Pre-seed Verified against 4 of 32 sources | $29.9M | 2026-10-22 | [ PART ] |
Othello A platform that uses AI to give salespeople real-time coaching tips to improve their sales calls | Seed Verified against 4 of 19 sources | $8M | 2026-10-14 | [ PART ] |
Flow Engineering The agentic platform for hardware development | Series B Verified against 1 of 30 sources | $50M | 2026-09-30 | [ PART ] |
RadixArk RadixArk builds large-scale inference and training systems for the entire AI community, making frontier-level AI infrastructure open and accessible. | Seed Verified against 1 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-05-05 | [ PART ] |
CuspAI CuspAI sells AI-powered materials discovery services targeted at technology and manufacturing companies. | Series A Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $99.5M | 2025-09-10 | [ PART ] |
Lovable An AI software creation platform | Pre-A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $15M | 2025-02-25 | [ PART ] |